Microfluidic single-cell transcriptional analysis rationally identifies novel surface marker profiles to enhance cell-based therapies

Current progenitor cell therapies have only modest efficacy, which has limited their clinical adoption. This may be the result of a cellular heterogeneity that decreases the number of functional progenitors delivered to diseased tissue, and prevents correction of underlying pathologic cell populatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Rennert, Robert C., Januszyk, Michael, Sorkin, Michael, Rodrigues, Melanie, Maan, Zeshaan N., Duscher, Dominik, Whittam, Alexander J., Kosaraju, Revanth, Chung, Michael T., Paik, Kevin, Li, Alexander Y., Findlay, Michael, Glotzbach, Jason P., Butte, Atul J., Gurtner, Geoffrey C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512622/
https://www.ncbi.nlm.nih.gov/pubmed/27324848
http://dx.doi.org/10.1038/ncomms11945

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5512622/
https://www.ncbi.nlm.nih.gov/pubmed/27324848
http://dx.doi.org/10.1038/ncomms11945

Ejemplares similares